An Interview with Jason Tardio, Chief Operating Officer of Ovid Therapeutics

Episode 82  ·  Jun 06, 2023, 04:17 PM
Headliner
Share
Subscribe

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jason Tardio, chief operating officer at Ovid Therapeutics,

Share
Subscribe
Next
An Interview with Kim Smith-Whitley, MD
Top episodes
An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
by Rare Care Podcast
An Interview With Omer Abdul Hamid, MD, of Nemours Children's Hospital in Orlando, Florida
by Rare Care Podcast
A Discussion on Medullary Thyroid Carcinoma With Dr. David Goldenberg
by Rare Care Podcast